Z-2559-2014 Class III Terminated
FDA device recall Z-2559-2014 was initiated by Nanosphere, Inc. on Mar 18, 2014 and is designated Class III. Reason for recall: Nanosphere has recieved reports related to an unacceptable increase in initial no-call rate when performing the Verigene CYP2C19 Nucleic Acid Test (2C19), which has been confirmed through internal… The recall status is terminated (terminated Jul 2, 2015). Affected quantity: 78 kits.
Recall details
- Product Type
- Devices
- Report Date
- Sep 3, 2014
- Initiation Date
- Mar 18, 2014
- Termination Date
- Jul 2, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 78 kits
Product description
Reason for recall
Distribution pattern
Worldwide Distribution - US including the states of AL, CA, MD, ND, NJ, OK and TX., and internationally to Bulgaria, China and New Zealand.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2559-2014
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Nanosphere, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.